BUZZ-泰拉生物科学公司完成4亿美元融资后股价上涨9月14日 - ** 泰拉生物科学公司(TYRA.O)周一开盘前股价上涨4.4%,报23美元,此前该公司成功完成4亿美元的股权融资
** 这家总部位于加利福尼亚州卡尔斯巴德的生物技术公司宣布, (link) 将发行约910万股股票及预先融资认股权证,用于认购约910万股股票
** 22.03美元的发行价与周五收盘价持平
** 公司计划将本次发行净所得款项用于推进达博格拉替尼(dabogratinib)在膀胱癌及软骨发育不全(一种影响骨骼生长的罕见遗传性疾病)领域的研发战略,以及其他用途
** 杰富瑞、古根海姆、坎托菲茨杰拉德、巴克莱和威廉·布莱尔担任联合簿记管理人
** 周三,由于达博格拉替尼(dabogratinib)在评估该药物治疗膀胱癌的II期研究中未达华尔街预期((link)),TYRA股价暴跌近18%,收于22.01美元
** 该公司流通股约为5970万股,市值约13亿美元
** 据伦敦证券交易所集团(LSEG)数据显示,16位分析师中有15位给予该股“强力买入”或“买入”评级,1位给予“持有”评级;目标价中位数为53美元
At the request of the copyright holder, you need to log in to view this content
LOGIN / SIGN UPDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.